Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02546570 · ClinicalTrials.gov registry record · Phase 2

Oxytocin and Affect Processing in Posttraumatic Stress Disorder

A Phase 2 study of Posttraumatic Stress Disorder (PTSD), sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase
11
Enrollment target
1
Study location

NCT02546570 is a Phase 2 study of Posttraumatic Stress Disorder (PTSD) that has completed, run by Yale University. The registered enrollment target is 11 participants, below the 115-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02546570, a Phase 2 study of Posttraumatic Stress Disorder (PTSD), has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The investigators will use multiple methods (including Oxytocin intranasal inhalation, neuroimaging, behavioral measures, peripheral hormone measurements) to examine how individuals' behavior, cognition, and brain function is impacted by the neuro-hormone Oxytocin. Specifically, the investigators plan to evaluate the influence of Oxytocin administration on affective processing in non-trauma exposed and trauma-exposed adults (both with and without posttraumatic stress disorder, PTSD).

Conditions Studied

Posttraumatic Stress Disorder (PTSD)

Interventions

  • DRUG Placebo
  • DRUG Oxytocin

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-08
Est. Completion 2016-08
Phase Phase 2

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02546570

The ClinicalTrials.gov registry entry for NCT02546570 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 115-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (90% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02546570 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02546570 about?

NCT02546570 is a clinical study titled "Oxytocin and Affect Processing in Posttraumatic Stress Disorder". The investigators will use multiple methods (including Oxytocin intranasal inhalation, neuroimaging, behavioral measures, peripheral hormone measurements) to examine how individuals' behavior, cognition, and brain function is impacted by the neuro-hormone Oxytocin. Specifically, the investigators pl...

What is the current status of trial NCT02546570?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2015-08. Estimated completion is 2016-08.

What conditions does trial NCT02546570 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD).

What interventions are being tested in trial NCT02546570?

The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).

Who is sponsoring clinical trial NCT02546570?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02546570 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Posttraumatic Stress Disorder (PTSD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Posttraumatic Stress Disorder (PTSD)

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.